Jul 8, 2025 Fuji Pharma and FRONTEO Launch Co-Creation Project to Evaluate Drug Discovery Seeds in the Women's Healthcare Field Accelerating Pharmaceutical R&D with the AI-Based Drug Discovery Support Service "Drug Discovery AI Factory"
Jun 29, 2025 Metagen Therapeutics and FRONTEO Launch Joint Research on Globally Watched Microbiome Drug Discovery Analyzing the Actions and Disease Associations of Gut Microbiota Using the Drug Discovery AI Factory
Jun 24, 2025 FRONTEO Accelerates U.S. Expansion — Signs Strategic Partnership Agreement with U.S.-based Q Partners, a Firm with Strengths in Life Sciences and Technology
May 14, 2025 FRONTEO and Chugai Pharmaceutical launch co-creation project for target discovery utilizing Drug Discovery AI Factory Accelerating R&D to Achieve First-in-Class and Best-in-Class Products Through Proprietary Technology That Systematically Discovers Unknown Disease–Molecule Correlations from Known Literature information.
May 12, 2025 FRONTEO and Institute of Science Tokyo Launch Joint Research on New Drug Discovery Targets Using the Drug Discovery AI Factory Verifying AI-Detected Drug Targets Through Both Dry and Wet Research to Develop Medicines Addressing Unmet Medical Needs
May 11, 2025 EA Pharma and FRONTEO Launch Co-Creation Project for AI-Powered Target Discovery in Drug Development
Jan 27, 2025 FRONTEO and Eisai launch co-creation project for target discovery using Drug Discovery AI Factory Accelerate First in Class R&D with FRONTEO’s unique technologies that systematically discover unreported relationships between diseases and molecules from existing literature information.
Jan 15, 2025 Publication of White Paper on innovative drug discovery approach using Springer Nature’s literature data and FRONTEO’s specialized AI engine KIBIT FRONTEO’s Drug Discovery AI Factory, an AI drug discovery service using unique technologies that discover unreported relationships from published literature, to support target identification and drug repositioning etc.
Jan 8, 2025 FRONTEO and Maruishi Pharmaceutical launch co-creation project for biomarker discovery using Drug Discovery AI Factory Accelerate pharmaceutical research and development with FRONTEO’s unique technologies that systematically discovers unreported relationships between diseases and molecules from existing literature.
Nov 13, 2024 UBE and FRONTEO launch co-creation project for drug repositioning using Drug Discovery AI Factory Accelerate indication identification and early licensing with FRONTEO’s unique technologies that systematically discovers unreported relationships between diseases and molecules from existing literature information.
Nov 11, 2024 FRONTEO and Daiichi Sankyo signed an agreement for optimization and analysis of toxicity information with Drug Discovery AI Factory Supporting the construction of innovative AI discovery systems to derive new findings from toxicity study database and toxicity study reports
May 12, 2024 FRONTEO, Shionogi, and Suzuken Collaborate to Implement Conversational Dementia Diagnosis Support AI Program in Society